Recurrent Paranasal Sinus Squamous Cell Carcinoma
5 clinical trials · Condition
◉ Watch Recurrent Paranasal Sinus Squamous Cell Carcinoma
| Record | Firm | Date |
|---|---|---|
| Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma (NCT07156227) | National Cancer Institute (NCI) | 2027-02-13 |
| Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation (NCT06662058) | Emory University | 2025-08-25 |
| Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial (NCT06636734) | Emory University | 2024-12-09 |
| Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck Cancer (NCT04576091) | National Cancer Institute (NCI) | 2022-07-06 |
| Prepare to Care, A Supported Self-Management Intervention for Head and Neck Cancer CaregiversHead and Neck Cancer (NCT03032250) | Wake Forest University Health Sciences | 2017-05-15 |
Track Recurrent Paranasal Sinus Squamous Cell Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.